98432248 - TETRAVECTA

Information

• Trademark
• 98432248

• Source

• Serial Number

  98432248

• International Classifications

  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 04, 2024
  10 months ago

• Transaction Date

  December 24, 2024
  11 days ago

• Status Date

  December 24, 2024
  11 days ago

• Location Date

  December 24, 2024
  11 days ago

• Status Code

  661

• Current Location

  TMO LAW OFFICE 110

  Employee Name

  NADELMAN, ANDREA

• Attorney Docket Number

  KILB.00060.T

  Attorney Name

  Rebeccah Gan

  Law Office Assigned Location Code

  M10

• Owners

  • OXFORD BIOMEDICA (UK) LIMITED

Case File Statements

• GS0401: Custom manufacture of products relating to biotechnology, namely, custom manufacture of cell and gene therapies; custom manufacture of gene and cell-based therapy products, namely, cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of cell and gene therapies, and biopharmaceutical preparations; biotechnology contract manufacturing services, namely, contract manufacturing in the field of cell and gene therapy using biological organisms; contract manufacturing services of gene and cell-based therapy products, namely, cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of cell and gene therapies and biopharmaceutical products, namely, cell and gene therapies; contract manufacturing services of technology for biopharmaceutical products and gene and cell-based products, namely, custom manufacture of cell and gene therapies; contract manufacturing services of technology for viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations, namely, custom manufacture of cell and gene therapies
• GS0421: Research and laboratory analytic and diagnostic services, namely, scientific research, biochemical research, research laboratory analysis services in the field of gene therapy and biochemistry; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector product and analytic assay product development for others; laboratory services, namely, scientific laboratory services and biological research laboratory services; research and development services, namely, gene therapy research; genetic engineering laboratories, namely, scientific research in the field of genetic engineering provided in genetic engineering laboratories and biochemistry laboratories providing research and development in the field of biochemistry; scientific and technological services and research, namely, scientific research, analysis, testing in the fields of gene therapy and biochemistry; industrial analysis services, namely, providing analysis services with respect to gene-therapy based product manufacturing for industrial purposes; provision of information relating to scientific research; provision of scientific information in the fields of gene therapy and biochemistry; product research and scientific analysis of cell and gene therapies relating to drug discovery and product development for others; scientific advisory services relating to biochemistry; scientific consultancy services relating to biochemistry; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals

Case File Event Statements

• 3/4/2024 - 10 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 7/15/2024 - 5 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/18/2024 - 3 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 9/25/2024 - 3 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/25/2024 - 3 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/25/2024 - 3 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/23/2024 - 12 days ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/23/2024 - 12 days ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/24/2024 - 11 days ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME